Dyne Therapeutics, Inc. Contracts & Agreements

47 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer letter, dated as of July 23, 2024, by and between the registrant and Douglas Kerr
Dyne Therapeutics, Inc.
2024
Consulting Agreement, dated as of August 30, 2024, by and between the registrant and Jonathan McNeill
Consulting Agreements
Dyne Therapeutics, Inc.
2024
Consulting Agreement, dated as of August 31, 2024, by and between the registrant and Susanna High
Consulting Agreements
Dyne Therapeutics, Inc.
2024
Underwriting Agreement, dated May 21, 2024, by and among the Company and Morgan Stanley & Co. LLC, Jefferies LLC, Stifel, Nicolaus & Company, Incorporated and Guggenheim...
Underwriting Agreements
Dyne Therapeutics, Inc.
2024
Form of Nonstatuory Stock Option Agreement under 2024 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
2024
Form of Restricted Stock Unit Agreement under 2024 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
2024
Offer Letter, dated March 21, 2024, between the Company and John Cox
Dyne Therapeutics, Inc.
2024
Separation Agreement, dated March 25, 2024, between the Company and Joshua Brumm
Separation Agreements
Dyne Therapeutics, Inc.
2024
Consulting Agreement, dated March 25, 2024, between the Company and Joshua Brumm
Consulting Agreements
Dyne Therapeutics, Inc.
2024
Dyne Therapeutics Inc. 2024 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
2024
Underwriting Agreement, dated January 4, 2024, by and among the Company and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Jefferies LLC, as representatives of the...
Underwriting Agreements
Dyne Therapeutics, Inc.
2024
Amended and Restated Executive Severance and Change in Control Benefits Plan
Change of Control Agreements
Dyne Therapeutics, Inc.
Biotechnology
DE
2022
DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
Dyne Therapeutics, Inc.
Biotechnology
2022
Lease by and between Dyne Therapeutics, Inc. and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020, as amended
Lease Agreements
Dyne Therapeutics, Inc.
Biotechnology
MA
2021
Severance agreement between Dyne Therapeutics, Inc. and Romesh Subramanian dated as of June 2, 2021
Severance Agreements
Dyne Therapeutics, Inc.
Biotechnology
MA
2021
Lease by and between Dyne Therapeutics, Inc. and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020, as amended
Lease Agreements
Dyne Therapeutics, Inc.
2021
Description of Securities Registered Under Section 12 of the Exchange Act
Dyne Therapeutics, Inc.
Biotechnology
2021
Offer letter, dated as of December 17, 2020, by and between the registrant and Wildon Farwell
Dyne Therapeutics, Inc.
Biotechnology
MA
2021
Form of Underwriting Agreement
Underwriting Agreements
Dyne Therapeutics, Inc.
Biotechnology
NY
2021
Lease, by and between the registrant and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020, as amended
Lease Agreements
Dyne Therapeutics, Inc.
Biotechnology
MA
2021
Lease, by and between Dyne Therapeutics, Inc. and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020
Lease Agreements
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Form of Underwriting Agreement
Underwriting Agreements
Dyne Therapeutics, Inc.
Biotechnology
NY
2020
Specimen Stock Certificate evidencing the shares of common stock
Stock Agreements
Dyne Therapeutics, Inc.
Biotechnology
2020
2018 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
2020
2020 Stock Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
2020
2020 Employee Stock Purchase Plan
Stock Agreements
Dyne Therapeutics, Inc.
Biotechnology
DE
2020
Amended and Restated Investors Rights Agreement dated as of August 7, 2020 by and among the registrant and the other parties thereto
Investor Rights Agreements
Dyne Therapeutics, Inc.
Biotechnology
DE
2020
2018 Stock Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
2020
Form of Stock Option Agreement under 2018 Stock Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
2020
Form of Restricted Stock Agreement under 2018 Stock Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
Biotechnology
DE
2020
2020 Stock Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
2020
Form of Stock Option Agreement under 2020 Stock Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
Biotechnology
2020
Form of Restricted Stock Agreement under 2020 Stock Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
Biotechnology
DE
2020
Form of Restricted Stock Unit Agreement under 2020 Stock Incentive Plan
Bonus & Incentive Agreements
Dyne Therapeutics, Inc.
2020
2020 Employee Stock Purchase Plan
Stock Agreements
Dyne Therapeutics, Inc.
Biotechnology
DE
2020
Sublease Agreement, dated May 20, 2019, by and between Arrakis Therapeutics, Inc., as sublandlord, and the registrant, as subtenant
Lease Agreements
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Form of Indemnification Agreement between the registrant and each of its executive officers and directors
Indemnification Agreements
Dyne Therapeutics, Inc.
Biotechnology
DE
2020
License Agreement, dated as of April 27, 2020, by and between the registrant and the University of Mons
License Agreements
Dyne Therapeutics, Inc.
2020
Loan and Security Agreement, dated as of February 20, 2020, by and between the registrant and Pacific Western Bank
Loan Agreements
Dyne Therapeutics, Inc.
2020
Offer letter, dated as of September 19, 2019, by and between the registrant and Joshua Brumm
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Offer letter, dated as of March 21, 2018, by and between the registrant and Romesh Subramanian
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Employment side letter, dated as of November 29, 2018, by and between the registrant and Romesh Subramanian
Employment Agreements
Dyne Therapeutics, Inc.
2020
Offer letter, dated as of December 21, 2018, by and between the registrant and Jonathan McNeill
Dyne Therapeutics, Inc.
2020
Offer letter, dated as of December 12, 2019, by and between the registrant and Oxana Beskrovnaya
Dyne Therapeutics, Inc.
2020
Offer letter, dated as of November 8, 2019, by and between the registrant and Richard Scalzo
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Offer letter, dated as of July 24, 2020, by and between the registrant and Susanna High
Dyne Therapeutics, Inc.
Biotechnology
MA
2020
Executive Severance and Change in Control Benefits Plan
Change of Control Agreements
Dyne Therapeutics, Inc.
Biotechnology
DE
2020